Biomarkers PCA3 and TMPRSS2-ERG: better together

被引:0
|
作者
机构
关键词
D O I
10.1038/nrurol.2014.38
中图分类号
学科分类号
摘要
引用
收藏
页码:129 / 129
相关论文
共 50 条
  • [41] Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer
    Musaelyan, A. A.
    Nazarov, V. D.
    Lapin, S., V
    Boriskin, A. G.
    Reva, S. A.
    Lebedev, D. G.
    Yakovlev, V. D.
    Viktorov, D. A.
    Toropovskiy, A. N.
    Emanuel, V. L.
    Al-Shukri, S. Kh
    Petrov, S. B.
    ONKOUROLOGIYA, 2020, 16 (02): : 65 - 73
  • [42] TMPRSS2-ERG and PTEN loss in prostate cancer
    Squire, Jeremy A.
    NATURE GENETICS, 2009, 41 (05) : 509 - 510
  • [43] KLK3, PCA3, and TMPRSS2-ERG Expression in the Peripheral Blood Mononuclear Cell Fraction From Castration-Resistant Prostate Cancer Patients and Response to Docetaxel Treatment
    Dijkstra, Siebren
    Leyten, Gisele H. J. M.
    Jannink, Sander A.
    de Jong, Hans
    Mulders, Peter F. A.
    van Oort, Inge M.
    Schalken, Jack A.
    PROSTATE, 2014, 74 (12): : 1222 - 1230
  • [44] TMPRSS2-ERG gene fusion in prostate cancer
    Burdova, Alena
    Bouchal, Jan
    Tavandzis, Spiros
    Kolar, Zdenek
    BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (04): : 502 - 510
  • [45] The TMPRSS2-ERG fusion in prostate cancer is associated with ERG expression, but not with outcome
    Gopalan, A.
    Leversha, M.
    Satagopan, J.
    Al-Ahmadie, H. A.
    Fine, S. W.
    Olgac, S.
    Tickoo, S. K.
    Reuter, V. E.
    Gerald, W. L.
    LABORATORY INVESTIGATION, 2007, 87 : 149A - 149A
  • [46] Identification of potential prostate cancer biomarkers associated with TMPRSS2-ERG fusion and PTEN deletions
    Almami, Amal A.
    CANCER RESEARCH, 2012, 72
  • [47] Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion
    Sung, Ji-Youn
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    Kang, So Young
    Choi, Yoon-La
    Kwon, Ghee Young
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (07) : 586 - 592
  • [48] The TMPRSS2-ERG fusion in prostate cancer is associated with ERG expression, but not with outcome
    Gopalan, A.
    Leversha, M.
    Satagopan, J.
    Al-Ahmadie, H. A.
    Fine, S. W.
    Olgac, S.
    Tickoo, S. K.
    Reuter, V. E.
    Gerald, W. L.
    MODERN PATHOLOGY, 2007, 20 : 149A - 149A
  • [49] Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
    Tallon, Lucile
    Luangphakdy, Devillier
    Ruffion, Alain
    Colombel, Marc
    Devonec, Marian
    Champetier, Denis
    Paparel, Philippe
    Decaussin-Petrucci, Myriam
    Perrin, Paul
    Vlaeminck-Guillem, Virginie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (08) : 13299 - 13316
  • [50] Improved prediction of prostate biopsy outcome using PCA3, TMPRSS2:ERG gene fusions and serum PSA
    Aubin, Sheila M.
    Miick, Siobhan
    Williamsen, Sarah
    Hodge, Petrea
    Meinke, Jessica
    Blase, Amy
    Hessels, Daphne
    Schalken, Jack A.
    Rittenhouse, Harry
    Groskopf, Jack
    JOURNAL OF UROLOGY, 2008, 179 (04): : 725 - 725